04:43:02India

Solid Biosciences Inc. (SLDB)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
-174,325,000
Operating income
-179,206,000
Earnings per share
-1.99
R&D expense
140,325,000

Growth and profitability

Return on equity
-96.84
Return on assets
-74.97

Balance sheet

Total assets
232,540,000
Total liabilities
52,530,000
Shareholders' equity
180,010,000
Cash and equivalents
59,900,000
Current ratio
6.14

Cash flow and ratios

Operating cash flow
-156,289,000
Free cash flow
-157,442,000

Shareholder returns

Shares outstanding
111,610,531
Book value per share
1.61
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Charlestown, MA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

Solid Biosciences Inc. trades on NASDAQ under the ticker symbol SLDB. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis